StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.08−0.91 (-18.24%)

Close on Nov 18, 2026Market cap $400.20MP/E –Yield –

aTYR PHARMA price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

aTYR PHARMA's price to book ratio was 0.3× on Nov 11, 2026, against 1.0× a year earlier. Over the last 5 years it ranged from 0.0× to 6.7×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×+0.3
2025Dec 31, 20250.0×−4.2
2024Dec 31, 20244.2×+3.4
2023Dec 29, 20230.8×+0.0
2022Dec 30, 20220.8×−0.9
2021Dec 31, 20211.8×+0.6
2020Dec 31, 20201.2×+0.6
2019Dec 31, 20190.6×+0.2
2018Dec 31, 20180.4×−1.1
2017Dec 29, 20171.4×+0.7
2016Dec 30, 20160.7×−1.1
2015Dec 31, 20151.8×–

More aTYR PHARMA figures

See a number that looks wrong?